Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia Brunner, Andrew M. Brunner, Andrew M. Less Current Opinion in Hematology. 30(2):38-44, March 2023. Abstract Abstract Favorite PDF Permissions Buy
Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication Maggioni, Giulia; Della Porta, Matteo G. Maggioni, Giulia; Della Porta, Matteo G. Less Current Opinion in Hematology. 30(2):30-37, March 2023. Abstract Abstract Favorite PDF Permissions Buy
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis Handa, Shivani; Ginzburg, Yelena; Hoffman, Ronald; More Handa, Shivani; Ginzburg, Yelena; Hoffman, Ronald; Kremyanskaya, Marina Less Current Opinion in Hematology. 30(2):45-52, March 2023. Abstract Abstract Favorite PDF Permissions Buy
Editorial: Molecular advances make the day in myeloid diseases Halene, Stephanie Halene, Stephanie Less Current Opinion in Hematology. 30(2):29, March 2023. Favorite PDF Permissions Buy
Is it the time to integrate novel sequencing technologies into clinical practice? VanOudenhove, Jennifer; Halene, Stephanie; Mendez, Lourdes VanOudenhove, Jennifer; Halene, Stephanie; Mendez, Lourdes Less Current Opinion in Hematology. 30(2):70-77, March 2023. Abstract Abstract Favorite PDF Permissions Buy
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis Handa, Shivani; Ginzburg, Yelena; Hoffman, Ronald; More Handa, Shivani; Ginzburg, Yelena; Hoffman, Ronald; Kremyanskaya, Marina Less Current Opinion in Hematology. 30(2):45-52, March 2023. Abstract Abstract Favorite PDF Permissions Buy
VEXAS: where do we stand 2 years later? Sujobert, Pierre; Heiblig, Maël; Jamilloux, Yvan Sujobert, Pierre; Heiblig, Maël; Jamilloux, Yvan Less Current Opinion in Hematology. 30(2):64-69, March 2023. Abstract Abstract Favorite PDF Permissions Buy
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis Handa, Shivani; Ginzburg, Yelena; Hoffman, Ronald; More Handa, Shivani; Ginzburg, Yelena; Hoffman, Ronald; Kremyanskaya, Marina Less Current Opinion in Hematology. 30(2):45-52, March 2023. Abstract Abstract Favorite PDF Permissions Buy
VEXAS: where do we stand 2 years later? Sujobert, Pierre; Heiblig, Maël; Jamilloux, Yvan Sujobert, Pierre; Heiblig, Maël; Jamilloux, Yvan Less Current Opinion in Hematology. 30(2):64-69, March 2023. Abstract Abstract Favorite PDF Permissions Buy
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis Handa, Shivani; Ginzburg, Yelena; Hoffman, Ronald; More Handa, Shivani; Ginzburg, Yelena; Hoffman, Ronald; Kremyanskaya, Marina Less Current Opinion in Hematology. 30(2):45-52, March 2023. Abstract Abstract Favorite PDF Permissions Buy
The fifth edition of the World Health Organization Classification and the International Consensus Classification of myeloid neoplasms: evolving guidelines in the molecular era with practical implications Zheng, Gang; Li, Peng; Zhang, Xiaohui; More Zheng, Gang; Li, Peng; Zhang, Xiaohui; Pan, Zenggang Less Current Opinion in Hematology. 30(2):53-63, March 2023. Abstract Abstract Favorite PDF Permissions Buy SDC
Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication Maggioni, Giulia; Della Porta, Matteo G. Maggioni, Giulia; Della Porta, Matteo G. Less Current Opinion in Hematology. 30(2):30-37, March 2023. Abstract Abstract Favorite PDF Permissions Buy
Is it the time to integrate novel sequencing technologies into clinical practice? VanOudenhove, Jennifer; Halene, Stephanie; Mendez, Lourdes VanOudenhove, Jennifer; Halene, Stephanie; Mendez, Lourdes Less Current Opinion in Hematology. 30(2):70-77, March 2023. Abstract Abstract Favorite PDF Permissions Buy
The fifth edition of the World Health Organization Classification and the International Consensus Classification of myeloid neoplasms: evolving guidelines in the molecular era with practical implications Zheng, Gang; Li, Peng; Zhang, Xiaohui; More Zheng, Gang; Li, Peng; Zhang, Xiaohui; Pan, Zenggang Less Current Opinion in Hematology. 30(2):53-63, March 2023. Abstract Abstract Favorite PDF Permissions Buy SDC
VEXAS: where do we stand 2 years later? Sujobert, Pierre; Heiblig, Maël; Jamilloux, Yvan Sujobert, Pierre; Heiblig, Maël; Jamilloux, Yvan Less Current Opinion in Hematology. 30(2):64-69, March 2023. Abstract Abstract Favorite PDF Permissions Buy
Is it the time to integrate novel sequencing technologies into clinical practice? VanOudenhove, Jennifer; Halene, Stephanie; Mendez, Lourdes VanOudenhove, Jennifer; Halene, Stephanie; Mendez, Lourdes Less Current Opinion in Hematology. 30(2):70-77, March 2023. Abstract Abstract Favorite PDF Permissions Buy
The fifth edition of the World Health Organization Classification and the International Consensus Classification of myeloid neoplasms: evolving guidelines in the molecular era with practical implications Zheng, Gang; Li, Peng; Zhang, Xiaohui; More Zheng, Gang; Li, Peng; Zhang, Xiaohui; Pan, Zenggang Less Current Opinion in Hematology. 30(2):53-63, March 2023. Abstract Abstract Favorite PDF Permissions Buy SDC
The fifth edition of the World Health Organization Classification and the International Consensus Classification of myeloid neoplasms: evolving guidelines in the molecular era with practical implications Zheng, Gang; Li, Peng; Zhang, Xiaohui; More Zheng, Gang; Li, Peng; Zhang, Xiaohui; Pan, Zenggang Less Current Opinion in Hematology. 30(2):53-63, March 2023. Abstract Abstract Favorite PDF Permissions Buy SDC
